Hyderabad: The State government on Friday constituted a committee of experts to oversee the allocation of Tocilizumab drug to Covid positive patients undergoing treatment at government and private hospitals across Telangana. The three-member committee includes Director of Nizam’s Institute of Medical Sciences (NIMS), Dr.K Manohar, Director of Medical Education (DME), Dr.Ramesh Reddy and Director of […]
As part of the review process, the drug major will present the safety profile of phase 2 study, and interim data of phase 3 trial, which is expected to be complete by February 21
Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future.
"Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible"